The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the ...
Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...
Drug compounders on Monday sued the U.S. Food and Drug Administration over its decision last week to remove Novo Nordisk's ...
Pfizer Inc. appointed the Food and Drug Administration’s former top drug reviewer to serve as its chief medical officer.
The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable ...
Some e-cigarette companies targeted by U.S. authorities have altered their business model or changed their corporate ...
The lawsuit claims the FDA's finding that there was no longer a shortage of the drugs' active ingredient semaglutide was ...
The reversal is the latest example of President Donald Trump and billionaire Elon Musk’s chaotic approach to cost-cutting, ...
After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...
The US Food and Drug Administration’s new standards for foods before they can be labeled as “healthy” on their packaging will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results